key: cord-0738733-pjh2lr22 authors: Chen, Can; Zhu, Changtai; Yan, Danying; Liu, Hongchao; Li, Danfeng; Zhou, Yuqing; Fu, Xiaofang; Wu, Jie; Ding, Cheng; Tian, Guo; Lan, Lei; Liu, Xiaoxiao; Huang, Chenyang; Hecht, Robert; Li, Lanjuan; Yang, Shigui title: The epidemiological and radiographical characteristics of asymptomatic infections with the novel coronavirus (COVID-19): A systematic review and meta-analysis date: 2021-01-12 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2021.01.017 sha: eede8a0ace93836660c6a8c6b6a83cf14faa0115 doc_id: 738733 cord_uid: pjh2lr22 Objectives The role of asymptomatic infections in the transmission of COVID-19 have drawn considerable attention. Here, we performed a meta-analysis to summarize the epidemiological and radiographical characteristics of asymptomatic infections with COVID-19. Methods Data on the epidemiological and radiographical characteristics of asymptomatic infections were extracted. Pooled proportions with 95% confidence intervals were calculated using a random effects model. Results A total of 104 studies involving 20,152 cases were included. The proportion of asymptomatic individuals among those with COVID-19 was 13.34% (10.86%-16.29%), among which the presymptomatic and covert infections were 7.64% (4.02%-14.04%) and 8.44% (5.12%-13.62%), respectively. The proportions of asymptomatic infections among infected children and healthcare workers were 32.24% (23.08%-42.13%) and 36.96% (18.51%-60.21%), respectively. The proportion of asymptomatic infections was significantly higher after 2020/02/29 than before (33.53% vs 10.19%) and in non-Asian regions than in Asia (28.76% vs 11.54%). The median viral shedding duration of asymptomatic infections was 14.14 days (11.25-17.04). A total of 47.62% (31.13%-72.87%) of asymptomatic infections showed lung abnormalities, especially ground-glass opacity 41.11% (19.7%-85.79%). Conclusions Asymptomatic infections were more often found in infected children and healthcare workers, and they increased after 2020/02/29 and in non-Asian regions. Chest radiographical imaging could be conducive to early identification of asymptomatic infections. Since COVID-19 was first reported in December 2019, it has spread rapidly worldwide [1] . The infectivity of COVID-19, which has a basic reproduction number (R0) ranging from 2 -6.7, was estimated to be much higher than that of influenza, severe acute respiratory syndrome (SARS) and middle east respiratory syndrome (MERS) [2] [3] [4] . Asymptomatic infections among patients with COVID-19 have been reported, including presymptomatic and covert infections, and they are differentiated according to whether related clinical symptoms appear during follow-up [5] . On "Diamond Princess", 189 asymptomatic individuals among the 1,723 tested travelers were identified as of 17 February 2020 [6] . Recently, asymptomatic infections in the transmission of COVID- 19 have drawn considerable attention. In previous studies, evidence of secondary cases caused by asymptomatic carriers has been identified [7] [8] [9] . Among the skilled nursing facilities in the United States, 56% (27/48) of cases were asymptomatic, and the median Ct values of reverse transcription-polymerase chain reaction (RT-PCR) were similar in covert, presymptomatic and symptomatic infections, which indicated substantial viral shedding from asymptomatic individuals [10] . The quantitative estimation showed that 56.1% of transmission occurred in the presymptomatic period [11] . When taking asymptomatic carriers into account, the R0 of COVID-19 could be up to 15.4 (range: 5.5-25.4) [12] . Therefore, asymptomatic infections should be considered a source of COVID- 19 infections that plays a momentous role in the spread of the virus. However, many studies have indicated that there are inconsistencies in the proportion of asymptomatic individuals with COVID-19 infection. A study based on the Diamond Princess cruise ship has found a considerable proportion of asymptomatic infections [6] . The China National Health Commission has reported that 130 of 166 new COVID-19 infections were asymptomatic on 1 April 2020 [13] . Nonetheless, a study indicated that J o u r n a l P r e -p r o o f the proportion of truly asymptomatic infections appears to be relatively low and does not appear to be a major driver of transmission [14] . Hence, in this study, we systematically pooled the data to quantify the proportion of asymptomatic individuals, including presymptomatic and covert infections, among those with COVID-19 to describe their epidemiological and radiographical characteristics, which could be conducive to developing prevention and control strategies for asymptomatic individuals. Our meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) guidelines [15] . A comprehensive systematic literature search of the studies published from January 1st, 2020 to May 13th, 2020 was conducted through databases including PubMed, medRxiv, bioRxiv, Web of Science, Cochrane, China National Knowledge Infrastructure (CNKI), SinoMed, Wangfang and VP. The search terms were "severe acute respiratory syndrome coronavirus 2", "COVID-19", "SARS-CoV-2", "asymptomatic", "presymptomatic", "covert infection" and related terms. The details are shown in Supplementary Table 1 . The inclusion criteria were as follows: i) the subjects included in the study were positive for COVID-19 detected by RT-PCR or serum antibody; ii) The asymptomatic individuals were those with presymptomatic and covert infections. Asymptomatic individuals were defined as persons who had no COVID-19-related clinical symptoms, but positive RT-PCR or serum antibody results were detected. Presymptomatic infections were defined as persons who were asymptomatic with positive RT-PCR or serum antibody results at the early phase of infections and then developed COVID-19-related clinical symptoms during J o u r n a l P r e -p r o o f follow-up. Covert infections were defined as persons who did not show any COVID-19related clinical symptoms during the whole course, but RT-PCR or serum antibody detection was positive [5] . In this meta-analysis, as some of the potential eligible studies were not explicit about the definition of asymptomatic, presymptomatic and covert infections, we also made the decision according to the authors'description. iii) studies with sample sizes ≥ 20 participants; and iv) studies with sufficient data to calculate the proportion of asymptomatic infections with COVID-19 (the number of asymptomatic infections/the total number of RT-PCR or serum antibody positives). The exclusion criteria were i) studies that included only patients with symptomatic COVID-19; ii) duplicated publication data; and iii) case reports, reviews and studies without original data (e.g., modeling studies). Seven reviewers (CC, DY, HL, DL, YZ, XF and CD) performed an initial screening of titles and abstracts to exclude studies that clearly contained no asymptomatic patients with COVID-19 or no suitable data for asymptomatic proportion calculation. All retained fulltext articles were scrutinized against the eligibility criteria by two independent reviewers (TG and LL). Disagreements and uncertainties in the studies screened and selected were resolved by consensus by all author. The collected data included basic study information (e.g., first author, titles), study population (e.g., close contact, cluster, family cluster, epidemiological investigation), the numbers of asymptomatic and total infections, the numbers of covert and presymptomatic infections (the data were available when the studies finished the follow-up), demographic data (e.g., age, sex), the time of viral shedding and radiographical findings (e.g., abnormal lung findings, ground-glass opacity (GGO)). If a study included more than one independent study population, each of them was extracted as a separate dataset in the meta-analysis. Data extraction from each study J o u r n a l P r e -p r o o f was performed by two independent investigators (XL and CH). Disagreements and uncertainties in the data extraction were resolved by consensus by all author. The scale recommended by the Agency for Healthcare Research and Quality [16] was used for quality assessment of the included studies. The scale consists of 11 items, and each item was assigned 1 point if the condition was fulfilled. According to the total score, the studies were categorized into low (0-3), moderate (4-7) and high quality (8) (9) (10) (11) . The articles and citations were managed in EndNote (version X9). The viral shedding duration is presented by the median and interquartile range (IQR) in the original papers; the ranges provided were converted to means and standard deviations (SDs) by using an online tool (http://www.comp.hkbu.edu.hk/~xwan/median2mean.html) developed by Dehui Luo [17] . Then, the median viral shedding duration of asymptomatic infections was estimated, and its 95% confidence intervals (CI) was reported. The proportion of asymptomatic infections was pooled, and their 95% CIs were reported with variance transformed to a normal distribution by arcsine transformation or Freeman-Tukey double arcsine transformation [18] . The heterogeneity among each study was assessed by I 2, and when I 2 > 50%, a random-effects model was chosen; otherwise, a fixedeffects model was used [19] . Data from studies grouped according to study-level characteristics were compared using subgroup analyses. The potential publication bias was appraised by funnel plot and Egger weighted regression [20] . Sensitivity analysis, which excluded preprint studies, was used to evaluate the robustness and reliability of the overall pooled proportion. R version 3.2.3. was used to perform the data clearing and analyses. The proportion of asymptomatic individuals among those with COVID-19 was 13.34% (Table 1) . Among the infections with COVID-19, the infected children were more likely to be asymptomatic (32.24%; 95% CI: 23.08% -42.13%) than adults (9.66%; 95% CI: 5.54% In asymptomatic infections, the median viral shedding duration was estimated to be 14. Figure 4A ). Covert infections were also more likely to be found in cluster infections, with a proportion The shapes of the funnel plots were relatively symmetric (Supplementary figure 7) . Egger weighted regression was also conducted, and the p-value was 0.8805 (P > 0.05), which indicated that no obvious publication bias was found. When preprint studies were excluded from the meta-analysis, the pooled proportion estimate was 11.77% (95% CI: 9.15% -15.01%), while the overall proportion with preprints includes was estimated to be 13.34% (95% CI: 10.86% -16.29%); the 95% CIs of the pooled proportions overlapped. In the subgroup analysis, no significant difference was found between the pooled proportions estimated among preprint studies and peer-reviewed published articles (P = 0.0681 > 0.05) (Supplementary figure 8) . Therefore, we consider that the result in our study was stable and that the inclusion of preprinted articles had no obvious impact on the results. Asymptomatic infection with COVID-19 has caused wide concern for preventing a possible epidemic rebound. Understanding asymptomatic infections is conducive to assessing the prevalence, transmission rate and case fatality rate (CFR) of COVID-19 infection, as well as to developing measures for containing COVID-19 epidemics. However, we know very little about the epidemiological characteristics, especially the J o u r n a l P r e -p r o o f proportion of asymptomatic infections among those with COVID-19. Two studies previously pooled the published data and aimed to determine the proportion of covert infections among COVID-19 patients. In the Byambasuren study, 5 studies were included that contained 413 cases, and the proportion of covert infections was estimated to be 16% [21] . In the study conducted by Nelson Aguirre-Duarte, 8 studies were included that contained 156 cases, and the proportion of covert infections was estimated to be 29% [22] . There was a significant discrepancy between these two studies, and the sample sizes of the included articles seemed to have a great impact on the results. In our study, we was estimated at 7.64%, while approximately 8.44% were covert infections, which were asymptomatic throughout the disease course and extended follow-up. We noticed that the proportion of asymptomatic infections in children was apparently higher than that in adults and elderly individuals. In a review of 72,314 cases in China, children younger than 10 years accounted for less than 1% of the cases [23] , and most infected children appeared to have a mild clinical course [24] . Despite being mild or asymptomatic, prolonged viral shedding in the respiratory tract and stool was observed in these cases. After illness onset, the duration of SARS-CoV-2 RNA shedding in nasopharyngeal/throat swabs and feces ranged from 6 to 22 days and at least 2 weeks to more than 1 month, respectively [25, 26] . A previous study reported that the median viral shedding duration among covert, presymptomatic and symptomatic infections was 12.1, J o u r n a l P r e -p r o o f 16.6 and 16.6, respectively [27] . In this study, the median viral shedding duration among asymptomatic individual was estimated to be 14.14 days. Although some studies have argued that clearance of virus in asymptomatic individuals was faster than in symptomatic individuals [27, 28] , RNA-negative conversion still occurred at least two weeks from onset. Due to the long duration of viral shedding and lack of visible features, asymptomatic individuals should be deemed an epidemiologically significant source of infection. A high proportion of asymptomatic individuals was also found in infected healthcare workers. Several reasons might contribute to this phenomenon. First, most affected healthcare workers were young adults, who only showed mild or moderate clinical symptoms [29, 30] . Second, healthcare workers, known to be a high-risk group for COVID-19 [31] , are tested urgently and intensively after exposure; therefore, infection is more likely to be identified at the presymptomatic stage. In our study, the proportion of asymptomatic infections, including covert infections, among COVID-19 patients increased after 2020/02/29. This result indicated that the virulence of COVID-19 seems to be declining. The CFR for COVID-19 was estimated at 2.58%, which was significantly lower than that for SARS-CoV (10%) and MER-CoV (35%) [32] [33] [34] . It seems that during the evolution of COVID-19, the virus tends to persistently and adaptively circulate among the population. This would also provide more opportunities for producing new mutant viruses hat adapt to human hosts during long-term interactions between humans and COVID-19 [35] . The increase in the proportion of asymptomatic infections and covert infections reduces the harm of COVID-19 to humans. This might also explain why the proportion of asymptomatic infections and covert infections in non-Asian regions was higher than that in Asian regions because studies conducted in non-Asian regions were mostly conducted after 2020/02/29. To contain the COVID-19 epidemic, effective measurements should be taken not only for J o u r n a l P r e -p r o o f detecting symptomatic cases but also for identifying asymptomatic infections. However, there are more challenges for the prevention and control of asymptomatic infections with COVID-19. Currently, the main prevention and control strategies for asymptomatic infections consist of three aspects. First, asymptomatic infections should be efficiently detected. Epidemiological investigations and close contact tracing must be conducted promptly among confirmed, suspected and imported cases [36] . Second, population-based surveillance and testing should be intensified. Several seroprevalence studies have been conducted among healthcare workers [31, 37] . It has been reported that testing asymptomatic healthcare workers weekly could reduce transmission by 16%-23% [38] . Third, for individuals, it is necessary to maintain personal protection, a safe social distance, good personal hygiene and face masks in crowded areas [39] . Our results could be used This study has several limitations. First, most included studies did not categorize asymptomatic infections into covert and presymptomatic infections, which may have led to some biases when estimating the proportion of covert and presymptomatic infections. Second, high statistical heterogeneity was found, which may be related to the study regions, study populations, study periods and sample sizes. Third, the majority of the studies were conducted in China, which may have regional differences. Therefore, it would be better to incorporate as many studies as possible with a broad geographic scope to obtain a more comprehensive understanding of the proportion of asymptomatic infections among COVID-19 patients. This was a large-scale study of the epidemiological characteristics and radiographical CZ and CC interpreted data and wrote the report. SY, LJ L, CZ and Robert Hecht revised the report from preliminary draft to submission. CC revised the report according to editors/reviewers comments. SY and CZ supervised the study. All authors have read and approved the manuscript. The authors have no conflicts of interest relevant to this article to disclose. This study was supported by grants from the National Natural Science Foundation of China (grant number：81672005, U1611264, 81001271, 81721091) and the Mega-Project of National Science and Technology for the 12th and 13th Five-Year Plan of China (grant number：2018ZX10715-014-002 and 2014ZX10004008). No applicable. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions Asymptomatic and presymptomatic cases of COVID-19 contribution to spreading the epidemic and need for targeted control strategies (in Chinese) en.wikipedia.org/wiki/Diamond_Princess_(ship) Presumed Asymptomatic Carrier Transmission of COVID-19 Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. The New England journal of medicine A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period. The Journal of infectious diseases Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. The New England journal of medicine Estimating presymptomatic transmission of COVID-19: a secondary analysis using published data Investigating the Impact of Asymptomatic Carriers on COVID-19 Transmission Covid-19: four fifths of cases are asymptomatic, China figures indicate Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations Introduction from the Agency for Healthcare Research and Quality Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Statistical methods in medical research Meta-analysis of prevalence Medical decision making : an international journal of the Society for Medical Decision Making Comparison of two methods to detect publication bias in metaanalysis Estimating the extent of true asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis The role of asymptomatic SARS-CoV-2 infections: rapid living systematic review and meta-analysis Characteristics of and Important Lessons From the COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention SARS-CoV-2 Infection in Children. The New England journal of medicine A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding Early viral clearance and antibody kinetics of COVID-19 among asymptomatic carriers Symptomatic Infection is Associated with Prolonged Duration of Viral Shedding in Mild Coronavirus Disease 2019: A Retrospective Study of 110 Children in Wuhan. The Pediatric infectious disease journal Estimating Coronavirus Disease 2019 Infection Risk in Health Care Workers COVID-2019) Infection Among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital SARS-CoV-2 infection in Health Care Workers in a large Middle East respiratory syndrome coronavirus (MERS-CoV) Emergence of Novel Coronavirus and COVID-19: whether to stay or die out? Critical reviews in microbiology SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis. mSystems Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infectious diseases of poverty Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission. eLife Role of testing in COVID-19 control Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic